Pirklbauer M - Search Results

1

Editorial: Personalized medicine in CKD patients.

Eisenga MF, Mayer G, Pirklbauer M, Provenzano M. Eisenga MF, et al. Among authors: pirklbauer m. Front Nephrol. 2023 Aug 16;3:1270382. doi: 10.3389/fneph.2023.1270382. eCollection 2023. Front Nephrol. 2023. PMID: 37675370 Free PMC article. No abstract available.

2

Bortezomib-induced survival signals and genes in human proximal tubular cells.

Sarközi R, Perco P, Hochegger K, Enrich J, Wiesinger M, Pirklbauer M, Eder S, Rudnicki M, Rosenkranz AR, Mayer B, Mayer G, Schramek H. Sarközi R, et al. Among authors: pirklbauer m. J Pharmacol Exp Ther. 2008 Dec;327(3):645-56. doi: 10.1124/jpet.108.142604. Epub 2008 Sep 5. J Pharmacol Exp Ther. 2008. PMID: 18776064

3

Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.

Schramek H, Sarközi R, Lauterberg C, Kronbichler A, Pirklbauer M, Albrecht R, Noppert SJ, Perco P, Rudnicki M, Strutz FM, Mayer G. Schramek H, et al. Among authors: pirklbauer m. Lab Invest. 2009 Nov;89(11):1304-16. doi: 10.1038/labinvest.2009.96. Epub 2009 Sep 7. Lab Invest. 2009. PMID: 19736548 Free article.

4

The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease.

Pirklbauer M, Mayer G. Pirklbauer M, et al. Nephrol Dial Transplant. 2011 Aug;26(8):2438-44. doi: 10.1093/ndt/gfr207. Epub 2011 May 5. Nephrol Dial Transplant. 2011. PMID: 21551087 Review.

5

Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.

Sarközi R, Hauser C, Noppert SJ, Kronbichler A, Pirklbauer M, Haller VM, Grillari J, Grillari-Voglauer R, Mayer G, Schramek H. Sarközi R, et al. Among authors: pirklbauer m. Am J Physiol Renal Physiol. 2011 Nov;301(5):F1014-25. doi: 10.1152/ajprenal.00123.2011. Epub 2011 Aug 3. Am J Physiol Renal Physiol. 2011. PMID: 21816755 Free article.

6

Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells.

Sarközi R, Flucher K, Haller VM, Pirklbauer M, Mayer G, Schramek H. Sarközi R, et al. Among authors: pirklbauer m. Biochem Biophys Res Commun. 2012 Aug 10;424(4):801-6. doi: 10.1016/j.bbrc.2012.07.042. Epub 2012 Jul 16. Biochem Biophys Res Commun. 2012. PMID: 22814105

7

FGF23 is associated with disease severity and prognosis in chronic heart failure.

Poelzl G, Trenkler C, Kliebhan J, Wuertinger P, Seger C, Kaser S, Mayer G, Pirklbauer M, Ulmer H, Griesmacher A. Poelzl G, et al. Among authors: pirklbauer m. Eur J Clin Invest. 2014 Dec;44(12):1150-8. doi: 10.1111/eci.12349. Epub 2014 Nov 3. Eur J Clin Invest. 2014. PMID: 25294008

8

Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human proximal tubular cells depends on STAT3 and p65 NFκB/RelA.

Sarközi R, Corazza U, Osterkamp JP, Pirklbauer M, Mayer G, Schramek H. Sarközi R, et al. Among authors: pirklbauer m. Physiol Rep. 2015 Feb 22;3(2):e12298. doi: 10.14814/phy2.12298. Print 2015 Feb 1. Physiol Rep. 2015. PMID: 25713326 Free PMC article.

9

Acute calcium kinetics in haemodialysis patients.

Pirklbauer M, Schupart R, Mayer G. Pirklbauer M, et al. Eur J Clin Invest. 2016 Dec;46(12):976-984. doi: 10.1111/eci.12680. Epub 2016 Oct 26. Eur J Clin Invest. 2016. PMID: 27689678

10

Unraveling reno-protective effects of SGLT2 inhibition in human proximal tubular cells.

Pirklbauer M, Schupart R, Fuchs L, Staudinger P, Corazza U, Sallaberger S, Leierer J, Mayer G, Schramek H. Pirklbauer M, et al. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F449-F462. doi: 10.1152/ajprenal.00431.2018. Epub 2018 Dec 12. Am J Physiol Renal Physiol. 2019. PMID: 30539648 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page